Long-term eradication of extranodal NK/T cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo
2019
Functionally rejuvenated
induced pluripotent stem cell-derived antigen-specific cytotoxic T lymphocytes are expected to be potent immunotherapy for tumors. When L-
asparaginase-containing standard chemotherapy fails in
extranodal NK/T cell lymphoma,
nasal type, no effective
salvage therapyexists. The clinical course then is miserable. We demonstrate prolonged and robust eradication of
extranodal NK/T cell lymphoma,
nasal type, in vivo by
Epstein-Barr virus-specific
induced pluripotent stem cell-derived antigen-specific cytotoxic T lymphocytes, with
induced pluripotent stem cell-derived antigen-specific cytotoxic T lymphocytes persisting as central
memory T cellsin mouse spleen for at least 6 months. The anti-tumor response is so strong that any concomitant effect of PD-1 blockade is unclear. These results suggest that long-term persistent
Epstein-Barr virus-specific
induced pluripotent stem cell-derived antigen-specific cytotoxic T lymphocytes contribute to continuous anti-tumor effect and offer an effective
salvage therapyfor relapsed and refractory
extranodal NK/T cell lymphoma,
nasal type.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
33
References
7
Citations
NaN
KQI